The Technical Analyst
Select Language :

MediciNova Inc [MNOV]

Exchange: NASDAQ Global Market Sector: Healthcare Industry: Biotechnology

Stock Price, Forecast, Insider, Ratings, Fundamentals & Signals

MediciNova Inc is listed at the NASDAQ Exchange

-9.80% $3.22

Last updated: 28 Nov 2021 @ 18:37 pm


FUNDAMENTALS
MarketCap: 157.92 mill
EPS: -0.232
P/E: 0.000
Earnings Date: Feb 16, 2022
SharesOutstanding: 49.04 mill
Avg Daily Volume: 0.442 mill
RATING 2021-11-26
B+
Buy
RATING DETAILS
Rating CashFlow: Strong Buy
Return On Equity: Neutral
Return On Asset: Neutral
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
2/203/204/201/212/213/21
Revenuen/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebit
Asset
Debtn/an/an/an/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 0.000 | sector: PE 371.73
PE RATIO: COMPANY / INDUSTRY
0.00x
Company: PE 0.000 | industry: PE 479.09
DISCOUNTED CASH FLOW VALUE
$5.32
(65.12%) $2.10
Date: 2021-11-28

Insider Trading

Date Person Action Amount type
2021-08-23 Matsuda Kazuko Buy 60 000 Common Stock
2021-08-23 Matsuda Kazuko Sell 60 000 Employee Stock Option (Right to Buy)
2021-07-09 Iwaki Yuichi Buy 39 583 Common Stock
2021-07-09 Iwaki Yuichi Sell 39 583 Employee Stock option (Right to Buy)
2021-06-24 Matsuda Kazuko Buy 56 250 Common Stock
INSIDER POWER
20.20
Last 100 transactions
Buy: 6 653 373 | Sell: 686 877

Forecast: 14:40 - $3.21

Live Trading Signals (every 1 min)

Forecast 1: 13:10 - $3.22
Forecast 2: 14:00 - $3.22
Forecast 3: 14:40 - $3.21
SCORE
3.63
Buy
Score Algorithm Version: 0.9M
Last version updated: Thurs 28th Oct 2021
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $3.22 (-9.80% )
Volume 0.465 mill
Avg. Vol. 0.442 mill
% of Avg. Vol 105.19 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for MediciNova Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for MediciNova Inc

RSI

Intraday RSI14 chart for MediciNova Inc
The Live Chart for MediciNova Inc
Profile picture for
            MediciNova Inc

MNOV

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has a collaboration agreement with BioComo and Mie University for joint development of a SARS-CoV-2 vaccine. MediciNova, Inc. was founded in 2000 and is headquartered in La Jolla, California.

Last 10 Buy Signals
Date Signal @
XRPUSDNov 28 - 13:180.911
DOGEUSDNov 28 - 13:12$0.196
XRPUSDNov 28 - 12:590.914
BTCUSDNov 28 - 12:3054 098
XRPUSDNov 28 - 12:260.920
XRPUSDNov 28 - 12:230.921
XRPUSDNov 28 - 12:190.922
BTCUSDNov 28 - 12:1654 220
XRPUSDNov 28 - 12:130.923
BTCUSDNov 28 - 12:1054 267

Stock Peers

Company Price Change
MNOV3.22-9.80%
ASLN1.5302.68%
CKPT3.14-3.09%
DBTX7.28-1.62%
GNFT3.350.45%
IIN17.892.46%
MRKR1.2300.00%
NMRD4.851.68%
SMTI28.65-1.21%
TCDA7.40-3.77%
VTVT1.340-2.19%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.